The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis

REFERENCES

• Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533–538.
   PubMed Web of Science ®Google Scholar
• Alexander, W. S., J. W. Schrader, and J. M. Adams. 1987. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice. Mol. Cell. Biol. 7:1436–1444.
   PubMed Web of Science ®Google Scholar
• ar-Rushdi, A., K. Nishikura, J. Erikson, R. Watt, G. Rovera, and C. M. Croce. 1983. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 222:390–393.
   PubMed Web of Science ®Google Scholar
• Bates, S., A. C. Phillips, P. A. Clark, F. Stott, G. Peters, R. L. Ludwig, and K. H. Vousden. 1998. p14ARF links the tumour suppressors RB and p53. Nature 395:124–125.
   PubMed Web of Science ®Google Scholar
• Baudino, T. A., K. H. Maclean, J. Brennan, E. Parganas, C. Yang, A. Aslanian, J. A. Lees, C. J. Sherr, M. F. Roussel, and J. L. Cleveland. 2003. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol. Cell 11:905–914.
   PubMed Web of Science ®Google Scholar
• Blyth, K., A. Terry, M. O'Hara, E. W. Baxter, M. Campbell, M. Stewart, L. A. Donehower, D. E. Onions, J. C. Neil, and E. R. Cameron. 1995. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10:1717–1723.
   PubMed Web of Science ®Google Scholar
• Chakrabarti, S. R., and G. Nucifora. 1999. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochem. Biophys. Res. Commun. 264:871–877.
   PubMed Web of Science ®Google Scholar
• Chen, H. M., and L. M. Boxer. 1995. Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol. Cell. Biol. 15:3840–3847.
   PubMedGoogle Scholar
• DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245–7250.
   PubMed Web of Science ®Google Scholar
• Dittmer, J., and A. Nordheim. 1998. Ets transcription factors and human disease. Biochim. Biophys. Acta 1377:F1–11.
   PubMedGoogle Scholar
• Eischen, C. M., J. D. Weber, M. F. Roussel, C. J. Sherr, and J. L. Cleveland. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:2658–2669.
   PubMed Web of Science ®Google Scholar
• Eischen, C. M., D. Woo, M. F. Roussel, and J. L. Cleveland. 2001. Apoptosis triggered by Myc-induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis. Mol. Cell. Biol. 21:5063–5070.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1997. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. Curr. Top. Microbiol. Immunol. 220:67–79.
   PubMed Web of Science ®Google Scholar
• Grillot, D. A., R. Merino, J. C. Pena, W. C. Fanslow, F. D. Finkelman, C. B. Thompson, and G. Nunez. 1996. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:381–391.
   PubMed Web of Science ®Google Scholar
• Gu, X., B. H. Shin, Y. Akbarali, A. Weiss, J. Boltax, P. Oettgen, and T. A. Libermann. 2001. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6. J. Biol. Chem. 276:9421–9436.
   PubMedGoogle Scholar
• Hayday, A. C., S. D. Gillies, H. Saito, C. Wood, K. Wiman, W. S. Hayward, and S. Tonegawa. 1984. Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus. Nature 307:334–340.
   PubMed Web of Science ®Google Scholar
• Irvin, B. J., L. D. Wood, L. Wang, R. Fenrick, C. G. Sansam, G. Packham, M. Kinch, E. Yang, and S. W. Hiebert. 2003. TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. J. Biol. Chem. 278:46378–46386.
   PubMedGoogle Scholar
• Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Kawagoe, H., M. Potter, J. Ellis, and G. C. Grosveld. 2004. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation. Cancer Res. 64:6091–6100.
   PubMedGoogle Scholar
• Koizumi, Y., S. Tanaka, R. Mou, H. Koganei, A. Kokawa, R. Kitamura, H. Yamauchi, K. Ookubo, T. Saito, S. Tominaga, K. Matsumura, H. Shimada, N. Tsuchida, and H. Sekihara. 1997. Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Clin. Cancer Res. 3:1067–1076.
   PubMed Web of Science ®Google Scholar
• Langdon, W. Y., A. W. Harris, S. Cory, and J. M. Adams. 1986. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47:11–18.
   PubMed Web of Science ®Google Scholar
• Lopez, R. G., C. Carron, C. Oury, P. Gardellin, O. Bernard, and J. Ghysdael. 1999. TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 274:30132–30138.
   PubMed Web of Science ®Google Scholar
• Mavrothalassitis, G., and J. Ghysdael. 2000. Proteins of the ETS family with transcriptional repressor activity. Oncogene 19:6524–6532.
   PubMed Web of Science ®Google Scholar
• Mazurenko, N., M. Attaleb, T. Gritsko, L. Semjonova, L. Pavlova, O. Sakharova, and F. Kisseljov. 1999. High resolution mapping of chromosome 6 deletions in cervical cancer. Oncol. Rep. 6:859–863.
   PubMedGoogle Scholar
• Mitelman, F., F. Mertens, and B. Johansson. 1997. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet. 15(Spec.):417–474.
   PubMedGoogle Scholar
• Moore, E., H. Magee, J. Coyne, T. Gorey, and P. A. Dervan. 1999. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS. J. Pathol. 187:403–409.
   PubMedGoogle Scholar
• Oikawa, T., and T. Yamada. 2003. Molecular biology of the Ets family of transcription factors. Gene 303:11–34.
   PubMed Web of Science ®Google Scholar
• Persons, D. A., J. A. Allay, E. R. Allay, R. J. Smeyne, R. A. Ashmun, B. P. Sorrentino, and A. W. Nienhuis. 1997. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90:1777–1786.
   PubMed Web of Science ®Google Scholar
• Poirel, H., R. G. Lopez, V. Lacronique, V. Della Valle, M. Mauchauffe, R. Berger, J. Ghysdael, and O. A. Bernard. 2000. Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL. Oncogene 19:4802–4806.
   PubMedGoogle Scholar
• Potter, M., A. Buijs, B. Kreider, L. V. Rompaey, and G. Grosveld. 2000. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6. Blood 95:3341–3348.
   PubMedGoogle Scholar
• Rabbitts, T. H. 1994. Chromosomal translocations in human cancer. Nature 372:143–149.
   PubMed Web of Science ®Google Scholar
• Randle, D. H., F. Zindy, C. J. Sherr, and M. F. Roussel. 2001. Differential effects of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc. Natl. Acad. Sci. USA 98:9654–9659.
   PubMedGoogle Scholar
• Raynaud, S., H. Cave, M. Baens, C. Bastard, V. Cacheux, J. Grosgeorge, C. Guidal-Giroux, C. Guo, E. Vilmer, P. Marynen, and B. Grandchamp. 1996. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891–2899.
   PubMed Web of Science ®Google Scholar
• Romana, S. P., H. Poirel, M. Leconiat, M. A. Flexor, M. Mauchauffe, P. Jonveaux, E. A. Macintyre, R. Berger, and O. A. Bernard. 1995. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263–4269.
   PubMed Web of Science ®Google Scholar
• Saffran, D. C., E. A. Faust, and O. N. Witte. 1992. Establishment of a reproducible culture technique for the selective growth of B-cell progenitors. Curr. Top. Microbiol. Immunol. 182:37–43.
   PubMedGoogle Scholar
• Sample, J. T. Burkitt lymphoma. In J. H. Tselis (ed.), Epstein-Barr virus, in press. Marcel Dekker, New York, N.Y.
   Google Scholar
• Sanchez-Beato, M., A. Sanchez-Aguilera, and M. A. Piris. 2003. Cell cycle deregulation in B-cell lymphomas. Blood 101:1220–1235.
   PubMed Web of Science ®Google Scholar
• Schmitt, C. A., and S. W. Lowe. 2002. Apoptosis and chemoresistance in transgenic cancer models. J. Mol. Med. 80:137–146.
   PubMedGoogle Scholar
• Schmitt, C. A., M. E. McCurrach, E. de Stanchina, R. R. Wallace-Brodeur, and S. W. Lowe. 1999. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:2670–2677.
   PubMed Web of Science ®Google Scholar
• Schmitt, C. A., R. R. Wallace-Brodeur, C. T. Rosenthal, M. E. McCurrach, and S. W. Lowe. 2000. DNA damage responses and chemosensitivity in the Eμ-myc mouse lymphoma model. Cold Spring Harbor Symp. Quant. Biol. 65:499–510.
   PubMedGoogle Scholar
• Sevilla, L., A. Zaldumbide, P. Pognonec, and K. E. Boulukos. 2001. Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NF-κB, STAT and AP1 transcription factor families. Histol. Histopathol. 16:595–601.
   PubMed Web of Science ®Google Scholar
• Stott, F. J., S. Bates, M. C. James, B. B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K. H. Vousden, and G. Peters. 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:5001–5014.
   PubMed Web of Science ®Google Scholar
• Strasser, A., A. W. Harris, M. L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331–333.
   PubMed Web of Science ®Google Scholar
• Tognon, C., S. R. Knezevich, D. Huntsman, C. D. Roskelley, N. Melnyk, J. A. Mathers, L. Becker, F. Carneiro, N. MacPherson, D. Horsman, C. Poremba, and P. H. Sorensen. 2002. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367–376.
   PubMed Web of Science ®Google Scholar
• Van Rompaey, L., W. Dou, A. Buijs, and G. Grosveld. 1999. Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. Neoplasia 1:526–536.
   PubMedGoogle Scholar
• Wang, L., F. Kuo, Y. Fujiwara, D. Gilliland, T. Golub, and S. Orkin. 1997. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16:4374–4383.
   PubMed Web of Science ®Google Scholar
• Wang, L., W. Swat, Y. Fujiwara, D. Gilliland, T. Golub, and S. Orkin. 1998. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12:2392–2402.
   PubMed Web of Science ®Google Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar
• Zindy, F., D. E. Quelle, M. F. Roussel, and C. J. Sherr. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203–211.
   PubMedGoogle Scholar